HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
•
***
This stock is shown as delisted in our database.
***
If you think this isn't correct then please
let us know
Life Technologies is a global biotechnology tools company. Co. provides a range of products and services, including systems, instruments, reagents, and custom services. Co.'s portfolio of products includes technologies for capillary electrophoresis based sequencing, polymerase chain reaction, sample preparation, cell culture, ribonucleic acid interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications, forensics, animal, food, pharmaceutical and water testing analysis. Co. operates its business under four divisions: Molecular Biology Systems; Genetic Systems; Cell Systems; and Mass Spectrometry.
| Market Cap | 13.142 Billion | Shares Outstanding | 172.83 Million | Avg Volume | 3.087 Million |
| 1-Yr BETA vs S&P TR | Current Ratio | 1.36 | Quick Ratio | 1.02 |
| Life Technologies Corp. Chart by YCharts | |
| Yahoo! Finance | finviz |
| SEC Web Site | SEC DEF 14A Filings |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
69,373 | 2020-02-13 | 0 | |
|
45,989 | 2020-02-13 | 0 | |
|
GIBSON KAREN SVP, IS & BUS. TRANSFORMATION |
|
1,193 | 2020-02-10 | 0 |
|
16,240 | 2020-02-10 | 0 | |
|
11,748 | 2020-01-02 | 0 | |
|
134,100 | 2019-10-31 | 0 | |
|
2,667,660 | 2019-09-17 | 0 | |
|
STEVENSON MARK EXECUTIVE VICE PRESIDENT & COO |
|
90,499 | 2019-08-27 | 0 |
|
|
105,597 | 2019-07-23 | 0 | |
|
ANDREWS RONALD ASBURY CHIEF EXECUTIVE OFFICER |
|
0 | 2019-07-01 | 0 |
|
0 | 2019-06-19 | 0 | |
|
0 | 2019-05-29 | 0 | |
|
0 | 2018-12-31 | 0 | |
|
0 | 2016-05-20 | 0 | |
|
0 | 2015-05-11 | 0 | |
|
COTTINGHAM JOHN A CHIEF LEGAL OFFICER |
|
No longer subject to file | 2014-02-03 | 0 |
|
No longer subject to file | 2014-02-03 | 0 | |
|
RICHARD KELLI CHIEF ACCOUNTING OFFICER |
|
No longer subject to file | 2014-02-03 | 0 |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
No longer subject to file | 2013-04-25 | 0 | |
|
No longer subject to file | 2012-04-26 | 0 | |
|
No longer subject to file | 2011-05-15 | 0 | |
|
BRUST BERND PRESIDENT, MOLECULAR MEDICINE |
|
No longer subject to file | 2011-05-02 | 0 |
|
MILLER JOHN L PRESIDENT, GENETIC SYSTEMS |
|
No longer subject to file | 2011-05-02 | 0 |
|
GROSSMAN PAUL DAVID SVP, CORPORATE STRATEGY & DEV. |
|
No longer subject to file | 2011-05-02 | 0 |
|
DANSKY PETER PRES, MOLECULAR BIOLOGY SYS |
|
No longer subject to file | 2011-05-02 | 0 |
|
O'DONNELL MARK SEAN SVP, GLOBAL OPS & SERVICES |
|
No longer subject to file | 2011-05-02 | 0 |
|
BEERY JOSEPH C SVP, CHIEF INFORMATION OFFICER |
|
No longer subject to file | 2011-05-02 | 0 |
|
BENCHIMOL CLAUDE SVP, ADVANCED GENOMIC SYSTEMS |
|
No longer subject to file | 2008-11-21 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | |||||||||
